Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGamma Communications Regulatory News (GAMA)

Share Price Information for Gamma Communications (GAMA)

Share Price is delayed by 15 minutes
Get Live Data
943.50    -10.50 (-1.10%)
Bid:
937.00
Ask:
938.50
Spread: 1.50 (0.16%)
Market Cap: £851.64m
GAMA Live PriceLast checked at - London Stock Exchange

Intraday Gamma Communications Share Chart

Trading Statement

11 Jan 2021 07:00

RNS Number : 1487L
Gamma Communications PLC
11 January 2021
 

11 January 2021

Gamma Communications plc

Trading Update

 

UCaaS product suite continues to deliver strong growth

Full year adj EBITDA and adj EPS anticipated to be slightly ahead of market expectations

 

Gamma Communications plc ("Gamma"), a leading provider of Unified Communication as a Service ("UCaaS"), announces a trading update for the year ended 31 December 2020.

 

Trading

We are pleased to report a financial performance significantly ahead of last year with adjusted EBITDA and adjusted EPS for the year ended 31 December 2020 expected to be slightly ahead of the range of market forecasts; revenues are expected to be towards the top of the range of expectations*. This performance reflects a continued strong demand in the UK and European business markets for Gamma's portfolio of UCaaS products.

 

Cash

The closing gross cash balance for the year was £54.1m compared to £53.9m at the end of the previous year. Net cash was £48.4m due to a small amount of debt within companies which were acquired.

 

The closing cash balance is above market expectations due to the sale of "The Loop". On 31 December 2020 Gamma sold its non-core Manchester based fibre business which traded as "The Loop" for an undisclosed sum. The business sold consisted of a duct and sub-duct based fibre network in Greater Manchester together with the customer base which includes major data centre operators, enterprises and public sector organisations. Gamma previously reported revenue of £0.7m for The Loop for the first half of 2020. 

 

The increase in cash balance from the previous year end is pleasing given that during the year Gamma spent £48.0m on acquisitions. These acquisitions have given Gamma an entry into both the German and Spanish markets as well as increasing both our market presence and product capabilties in the UK and the Netherlands.

 

Gamma has also maintained its dividend policy, despite the Covid 19 pandemic, and paid dividends to shareholders totalling £10.4m in 2020. It did not receive any government funding or support.

 

Overview of the year

 

Some of the highlights from the year include:

 

· The business performed well throughout 2020 despite the economic downturn caused by Covid-19. Its recurring revenue model has proved robust and its product set supports businesses which have had to work remotely. The group has seen cancellations and bad debt remain at the low levels experienced historically. 

· During the year, the group acquired UCaaS providers in two additional countries - Voz Telecom (Spain) and HFO Telecom (Germany). Integration is going well. The UCaaS market in both countries is significantly less developed than in the UK but is expected to grow rapidly.

· Gamma also acquired Exactive in the UK (which supports companies wishing to use Microsoft Teams as a UCaaS solution) and GnTel in the Netherlands (which provides a product capability and opens up a new route to market through partners who are based in the IT space)

· The group has continued to develop its product suites and expects to launch its Cloud Contact Centre as a Service ("CCaaS") solution during the first half of 2021; this will be targeted at the SME market.

 

The Board expects to announce results for the year ended 31 December 2020 on Tuesday 23 March.

 

 

Andrew Taylor, Chief Executive, commented on the results:

"We are pleased that Gamma has continued to grow strongly whilst also geographically expanding into Spain and Germany. The execution of our UCaaS product strategy is progressing very well and our product set has continued to perform well and has enabled our end users to work flexibly during the difficult conditions prevalent in 2020. I would like to thank our staff and partners for all of their hard work throughout the year."

 

END

 

* Note: Company compiled consensus ranges for Revenue are £371.8m - £396.7m; Adjusted EBITDA £73.9m - £76.0m; and Adjusted EPS 47.0p - 51.0p.

 

Gamma Communications plc

Andrew Taylor, Chief Executive Officer

Andrew Belshaw, Chief Financial Officer

Tel: +44 (0) 333 006 5972

 

 

Tulchan Communications LLP

James Macey White / Matt Low

Tel: +44 (0) 207 353 4200

 

 

Investec Bank plc (NOMAD & Broker)

Tel: +44 (0) 207 597 5970

Patrick Robb / Virginia Bull

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZGGMRRMGMZM
Date   Source Headline
15th Nov 202310:31 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSBlock listing Interim Review
1st Nov 202311:13 amRNSTotal Voting Rights
13th Oct 20233:59 pmRNSDirector/PDMR Shareholding
2nd Oct 20232:34 pmRNSTotal Voting Rights
14th Sep 20234:12 pmRNSIssue of Equity
14th Sep 20237:00 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSHalf-year Report
1st Sep 20237:00 amRNSTotal Voting Rights
25th Aug 20232:25 pmRNSHolding(s) in Company
15th Aug 20234:24 pmRNSDirector/PDMR Shareholding
2nd Aug 20237:00 amRNSTrading Statement
1st Aug 20237:00 amRNSTotal Voting Rights
13th Jul 20232:04 pmRNSDirector/PDMR Shareholding
3rd Jul 202312:11 pmRNSDirector/PDMR Shareholding
3rd Jul 202310:43 amRNSTotal Voting Rights
13th Jun 20235:03 pmRNSDirector/PDMR Shareholding
9th Jun 202312:35 pmRNSDirector/PDMR Shareholding
1st Jun 20232:19 pmRNSTotal Voting Rights - Replacement
1st Jun 202312:17 pmRNSTotal Voting Rights
30th May 202310:05 amRNSBlock Listing Application
25th May 20237:00 amRNSAppointment of Chair
23rd May 20234:12 pmRNSDirector/PDMR Shareholding
17th May 20235:08 pmRNSCommittee Composition
17th May 20234:25 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Trading update
15th May 202311:46 amRNSDirector/PDMR Shareholding
10th May 20237:00 amRNSDirector/PDMR Shareholding
9th May 20239:44 amRNSBlock listing Interim Review
2nd May 202310:09 amRNSTotal Voting Rights
20th Apr 20234:33 pmRNSPublication of Notice of AGM
13th Apr 202311:31 amRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 202311:42 amRNSDirector/PDMR Shareholding
28th Mar 202312:43 pmRNSHolding(s) in Company
21st Mar 20237:01 amRNSFinal Results
21st Mar 20237:00 amRNSChair succession planning
16th Mar 20237:00 amRNSDirectorate Change
14th Mar 20239:43 amRNSDirector/PDMR Shareholding
1st Mar 20232:01 pmRNSTotal Voting Rights
1st Mar 20239:32 amRNSHolding(s) in Company
17th Feb 20237:30 amRNSDirector/PDMR Shareholding
1st Feb 20235:47 pmRNSTotal Voting Rights
27th Jan 202312:44 pmRNSHolding(s) in Company
18th Jan 20235:21 pmRNSHolding(s) in Company
17th Jan 202310:34 amRNSDirector/PDMR Shareholding
12th Jan 20237:00 amRNSFull year growth expectations remain unchanged
11th Jan 20232:30 pmRNSTotal Voting Rights
11th Jan 20231:28 pmRNSHolding(s) in Company
10th Jan 202311:47 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.